Roche
ROG.SW
#36
Rank
NZ$569.91 B
Marketcap
NZ$710.39
Share price
1.88%
Change (1 day)
44.29%
Change (1 year)

EPS for Roche (ROG.SW)

EPS in 2023: NZ$29.72

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$29.72. In 2023 the company made an earnings per share (EPS) of NZ$29.72 an increase over its 2022 EPS that were of NZ$29.15.

EPS history for Roche from 1998 to 2023

Annual EPS

Year EPS Change
2023NZ$29.721.95%
2022NZ$29.15-6.29%
2021NZ$31.10-5.53%
2020NZ$32.9316.56%
2019NZ$28.2530.3%
2018NZ$21.6820.22%
2017NZ$18.03-5.81%
2016NZ$19.144.62%
2015NZ$18.30-5.13%
2014NZ$19.29-25.05%
2013NZ$25.7421.73%
2012NZ$21.143.82%
2011NZ$20.368.16%
2010NZ$18.8323.72%
2009NZ$15.22-12.31%
2008NZ$17.35-0.34%
2007NZ$17.4132.13%
2006NZ$13.1842.56%
2005NZ$9.24-22.7%
2004NZ$11.96132.85%
2003NZ$5.14-148.96%
2002NZ-$10.49-209.09%
2001NZ$9.61-57.25%
2000NZ$22.4954.06%
1999NZ$14.6031.24%
1998NZ$11.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.11-39.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.18-55.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.43-78.36%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$12.77-57.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$6.24-79.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Abbott Laboratories
ABT
NZ$13.98-52.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.61-23.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.66-67.48%๐Ÿ‡บ๐Ÿ‡ธ USA